Will an mRNA RSV vaccine be available by the end of 2025?

#Science #Biology

413

Ṁ687

Ṁ160

2026

83%

chance

ALL

Recent interview with Moderna's CEO:

"As you were saying, part of this is forward-looking because you have this platform technology [mRNA] that you feel is going to produce more vaccines. What’s next?

Flu is the next one. It could be as early as 2023. And on RSV [respiratory syncytial virus], there’s been some interesting news in the field because the world has needed an RSV vaccine for decades."

https://www.wsj.com/articles/modernas-ceo-on-its-new-covid-19-booster-prospects-for-cancer-vaccines-11663339811?st=p9hfwwo5y886buu&reflink=desktopwebshare_permalink

I will resolve "Yes" if any RSV mRNA vaccine is approved or given an emergency use authorization by the FDA, and it is available for the general public, for a specific age-group (e.g. 65 years or older) or for a group with certain health conditions (e.g. moderately or severely immunocompromised).

Oct 27, 10:30am: ~~Will an mRNA RSV vaccine be available by 2025?~~ → Will an mRNA RSV vaccine be available by the end of 2025?

Get Ṁ600 play money

Related questions

Will a vaccine for Lyme disease be available to the US public by the end of 2025?

46% chance

Will FDA approve any mRNA vaccine against malaria before 2028?

45% chance

Will the FDA issue an EUA or full approval for an mRNA H5N1 vaccine by 2025?

25% chance

Will FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?

38% chance

Will an mRNA HIV vaccine pass Phase 2 trials by 2025

22% chance

Will development of a universal flu vaccine have made significant progress by 2026?

56% chance

Will a new tuberculosis vaccine be available by the end of 2032?

72% chance

Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?

63% chance

Will FDA approve any mRNA vaccine against any strain of influenza before 2028?

78% chance

Will the number of children vaccinated with 3 doses of the R21 malaria vaccine reach 5M before January 1st, 2025?

Sort by:

bought Ṁ57 of YES

"Moderna Reports RSV Vaccine Cuts Risk of Respiratory Diseases in Older Adults [...] Citing the results, the Cambridge, Mass., company said Tuesday it would apply in the coming months for U.S. regulatory approval to sell its vaccine against RSV, which stands for respiratory syncytial virus. If regulators approve the vaccine, it could become available by early 2024, the company said."
https://www.wsj.com/articles/modernas-rsv-vaccine-reduces-risk-of-respiratory-diseases-study-finds-11673986424?st=61xsgkwaf26x0i0&reflink=desktopwebshare_permalink